Skip to search formSkip to main contentSkip to account menu

UK 109,496

Known as: UK-109496, UK-109,496, UK 109496 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Abstracts of the 35th Interscience Con-ference on Antimicrobial Agents and Chemotherapy. American Society forMicrobiology… 
2013
2013
Abstracts of the 35th Interscience Conference on Antimicrobial Agents andChemotherapy. American Society for Microbiology… 
Review
2010
Review
2010
1. Tadros TS, Workowoski KA, Siegel RJ, Hunter SH; Schwartz DA. Pathology of Hyalohyphomycosis caused by Scedosporium apiospermum… 
2002
2002
1. Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis… 
2002
2002
1. Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis… 
Review
1999
Review
1999
Voriconazole, also known in early reports as UK-109,496, was developed by Pfizer Central Research, UK. In 1995 at the 35 th… 
1997
1997
Voriconazole (CAS 137234-62-9, UK-109,496), a new antifungal triazole derivative, was studied in vitro against 650 clinical… 
1995
1995
&Several pharmaceutical companies worldwide have joined in a race to develop new antifungal agents for patients with compromised…